136 related articles for article (PubMed ID: 16403570)
1. The antinociceptive effects of the systemic adenosine A1 receptor agonist CPA in the absence and in the presence of spinal cord sensitization.
Curros-Criado MM; Herrero JF
Pharmacol Biochem Behav; 2005 Dec; 82(4):721-6. PubMed ID: 16403570
[TBL] [Abstract][Full Text] [Related]
2. Spinal vs. supraspinal antinociceptive activity of the adenosine A(1) receptor agonist cyclopentyl-adenosine in rats with inflammation.
Ramos-Zepeda G; Schröder W; Rosenow S; Herrero JF
Eur J Pharmacol; 2004 Sep; 499(3):247-56. PubMed ID: 15381046
[TBL] [Abstract][Full Text] [Related]
3. Interaction of the adenosine A1 receptor agonist N6-cyclopentyladenosine (CPA) and opioid receptors in spinal cord nociceptive reflexes.
Ramos-Zepeda G; Herrero JF
Life Sci; 2013 Aug; 93(5-6):233-9. PubMed ID: 23810661
[TBL] [Abstract][Full Text] [Related]
4. The antinociceptive effect of systemic gabapentin is related to the type of sensitization-induced hyperalgesia.
Curros-Criado MM; Herrero JF
J Neuroinflammation; 2007 Jun; 4():15. PubMed ID: 17550605
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of wind-up by the combined administration of adenosine A1 receptor ligands on spinalized rats with carrageenan-induced inflammation.
Ramos-Zepeda G; Herrero JF
Neurosci Lett; 2005 Aug 12-19; 384(1-2):177-82. PubMed ID: 15893424
[TBL] [Abstract][Full Text] [Related]
6. Effects of single and long-term theophylline treatment on the threshold of mechanical nociception: contribution of adenosine A1 and alpha2-adrenoceptors.
Pechlivanova DM; Georgiev VP
Methods Find Exp Clin Pharmacol; 2005 Nov; 27(9):659-64. PubMed ID: 16357952
[TBL] [Abstract][Full Text] [Related]
7. The role of intraspinal adenosine A1 receptors in sympathetic regulation.
Peng SC; Ho CM; Ho ST; Tsai SK; Su CK
Eur J Pharmacol; 2004 May; 492(1):49-55. PubMed ID: 15145705
[TBL] [Abstract][Full Text] [Related]
8. Interaction of the adenosine A1 receptor agonist N6-cyclopentyladenosine and κ-opioid receptors in rat spinal cord nociceptive reflexes.
Ramos-Zepeda GA; Herrero-Zorita C; Herrero JF
Behav Pharmacol; 2014 Dec; 25(8):741-9. PubMed ID: 25325292
[TBL] [Abstract][Full Text] [Related]
9. Selectivity of action of 8-alkylamino analogues of N6-cyclopentyladenosine in vivo: haemodynamic versus anti-lipolytic responses in rats.
van Schaick EA; Tukker HE; Roelen HC; IJzerman AP; Danhof M
Br J Pharmacol; 1998 Jun; 124(3):607-18. PubMed ID: 9647488
[TBL] [Abstract][Full Text] [Related]
10. Modulation of insulin release by adenosine A1 receptor agonists and antagonists in INS-1 cells: the possible contribution of 86Rb+ efflux and 45Ca2+ uptake.
Töpfer M; Burbiel CE; Müller CE; Knittel J; Verspohl EJ
Cell Biochem Funct; 2008 Dec; 26(8):833-43. PubMed ID: 18979526
[TBL] [Abstract][Full Text] [Related]
11. Adenosine A1 but not A2a receptor agonist reduces hyperalgesia caused by a surgical incision in rats: a pertussis toxin-sensitive G protein-dependent process.
Zahn PK; Straub H; Wenk M; Pogatzki-Zahn EM
Anesthesiology; 2007 Nov; 107(5):797-806. PubMed ID: 18073555
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic-pharmacodynamic relationship of the cardiovascular effects of adenosine A1 receptor agonist N6-cyclopentyladenosine in the rat.
Mathôt RA; van Schaick EA; Langemeijer MW; Soudijn W; Breimer DD; Ijzerman AP; Danhof M
J Pharmacol Exp Ther; 1994 Feb; 268(2):616-24. PubMed ID: 8113972
[TBL] [Abstract][Full Text] [Related]
13. Negative chronotropic response to adenosine receptor stimulation in rat right atria after run training.
Priviero F; De Nucci G; Antunes E; Zanesco A
Clin Exp Pharmacol Physiol; 2004 Oct; 31(10):741-3. PubMed ID: 15554918
[TBL] [Abstract][Full Text] [Related]
14. Antilipolytic activity of a novel partial A1 adenosine receptor agonist devoid of cardiovascular effects: comparison with nicotinic acid.
Dhalla AK; Santikul M; Smith M; Wong MY; Shryock JC; Belardinelli L
J Pharmacol Exp Ther; 2007 Apr; 321(1):327-33. PubMed ID: 17204748
[TBL] [Abstract][Full Text] [Related]
15. Antinociceptive interactions of triple and quadruple combinations of endogenous ligands at the spinal level.
Horvath G; Kekesi G; Tuboly G; Benedek G
Brain Res; 2007 Jun; 1155():42-8. PubMed ID: 17482581
[TBL] [Abstract][Full Text] [Related]
16. Central or peripheral delivery of an adenosine A1 receptor agonist improves mechanical allodynia in a mouse model of painful diabetic neuropathy.
Katz NK; Ryals JM; Wright DE
Neuroscience; 2015 Jan; 285():312-23. PubMed ID: 25451280
[TBL] [Abstract][Full Text] [Related]
17. Adenosine A1 receptor-mediated inhibition of dopamine release from rat striatal slices is modulated by D1 dopamine receptors.
O'Neill C; Nolan BJ; Macari A; O'Boyle KM; O'Connor JJ
Eur J Neurosci; 2007 Dec; 26(12):3421-8. PubMed ID: 18052983
[TBL] [Abstract][Full Text] [Related]
18. Adenosine A1 receptor agonist N6-cyclopentyladenosine affects the inactivation of acetylcholinesterase in blood and brain by sarin.
Bueters TJ; Joosen MJ; van Helden HP; Ijzerman AP; Danhof M
J Pharmacol Exp Ther; 2003 Mar; 304(3):1307-13. PubMed ID: 12604711
[TBL] [Abstract][Full Text] [Related]
19. [Protective effect of adenosine receptor agonists in a model of spinal cord injury in rats].
Sufianova GZ; Usov LA; Sufianov AA; Perelomov IuP; Raevskaia LIu; Shapkin AG
Eksp Klin Farmakol; 2002; 65(5):58-61. PubMed ID: 12596519
[TBL] [Abstract][Full Text] [Related]
20. Repetitive stimulation of adenosine A1 receptors in vivo: changes in receptor numbers, G-proteins and A1 receptor agonist-induced hypothermia.
Roman V; Keijser JN; Luiten PG; Meerlo P
Brain Res; 2008 Jan; 1191():69-74. PubMed ID: 18163981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
